On October 30, 2018, CMS published an Advanced Notice of Proposed Rulemaking for a potential International Pricing Index (IPI) Model for Medicare Part B Drugs. The model would be phased in over a five-year period and will be tested as a pilot program through the CMS Center for Medicare and Medicaid Innovation. The model is intended to lower expenditures for Part B drugs by implementing an international reference price to shift payments to a level that is comparable with prices in other countries. It also seeks to reform the current “buy and bill” system for Part B drugs and alter reimbursement methodology to eliminate existing incentives to prescribe higher-cost drugs.
Press Release: The Academy of Managed Care Pharmacy and AMCP Foundation last night recognized a group of leaders who have contributed significantly to the profession of managed care pharmacy.
Press Release: The Academy of Managed Care Pharmacy (AMCP) Foundation is delighted to announce that eight student pharmacists from across the country recently completed summer internship programs organized by the Foundation and supported by Pfizer, Inc.
Partnership Forum: Industry leaders gathered June 10-11, 2015 to address the current readiness of MCOs to optimize biosimilars and identify gaps and resources needed.
This downloadable and shareable presentation describes key components of a medication therapy management (MTM) Part D program, the value of MTM programs within health care and the role of the pharmacist.